The effect of propolis in experimental Acanthamoeba keratitis

Clinical and Experimental Ophthalmology

Volumn 35, Issue 8, 2007, Pages 749-754

  Vural, Ayse ^a   Polat, Zubeyde Akin ^a   Topalkara, Aysen ^a   Toker, Mustafa Ilker ^a   Erdogan, Haydar ^a   Arici, Mustafa Kemal ^a   Cetin, Ali ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acanthamoeba; Chlorhexidine; Keratitis; Propolis

Indexed keywords

C 9394; CHLORHEXIDINE; LUBRICATING AGENT; PROPOLIS; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL CULTURE; CELL DAMAGE; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG CYTOTOXICITY; EPITHELIUM CELL; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MONOTHERAPY; NONHUMAN; RAT; SLIT LAMP; TOXICITY TESTING;

ACANTHAMOEBA KERATITIS; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIPROTOZOAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; CHLORHEXIDINE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EPITHELIUM, CORNEAL; PROPOLIS; RATS; RATS, WISTAR;

EID: 36049012227     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2007.01620.x     Document Type: Article

References (24)

1. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol 2003; 16: 273-307.
2. Khan NA. Pathogenicity, morphology, and differentiation of Acanthamoeba. Curr Microbiol 2001; 43: 391-5.
3. Cardine S, Bourcier T, Chaumeil C, Zamfir O, Borderie V, Laroche L. Clinical management, and prognosis in Acanthamoeba keratitis. a retrospective study of 25 cases. J Fr Ophtalmol 2002; 25: 1007-13.
4. Kilvington S, Larkin DF, White DG, Beeching JR. Laboratory investigation of Acanthamoeba keratitis. J Clin Microbiol 1990; 28: 2722-5.
5. Kusumoto T, Miyamoto T, Higuchi R, Doi S, Sugimoto H, Yamada H. Isolation and structures of two new compounds from the essential oil of Brazilian propolis. Chem Pharm Bull 2001; 49: 1207-9.
6. Marcucci MC. Propolis: Chemical composition, biological properties, and therapeutic activity. Apidologie 1995; 26: 83-99.
7. Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytother Res 2001; 15: 561-71.
8. Sa-Nunes A, Faccioli LH, Sforcin JM. Propolis. lymphocyte proliferation and IFN-gamma production. J Ethnopharmacol 2003; 87: 93-7.
9. Topalkara A, Vural A, Polat Z et al. In vitro amoebicidal activity of propolis on Acanthamoeba castellanii. J Ocul Pharmacol Ther 2007; 23: 40-5.
10. Naor J, Savion N, Blumenthal M, Assia EI. Corneal endothelial cytotoxicity of diluted povidone -iodine. J Cataract Refract Surg 2001; 27: 941-7.
11. Walochnik J, Obwaller A, Aspock H. Correlations between morphological, molecular biological, and physiological characteristics in clinical and nonclinical isolates of Acanthamoeba spp. Appl Environ Microbiol 2000; 66: 4408-13.
12. Schuster FL. Cultivation of pathogenic and opportunistic free-living amebas. Clin Microbiol 2002; 15: 342-54.
13. Larkin DF, Easty DL. Experimental Acanthamoeba keratitis. I. Preliminary findings. Br J Ophthalmol 1990; 74: 551-5.
14. Osato MS, Robinson NM, Wilhelmus KR, Jones DB. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba. Rev Infect Dis 1991; 13: 431-5.
15. Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992; 99: 185-91.
16. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance, and Acanthamoeba keratitis: The quest for alternative antiprotozoal chemotherapy. Eye 1994; 8: 555-63.
17. Seal DV, Hay J, Kirkness CM. Chlorhexidine or polyhexamethylene biguanide for Acanthamoeba keratitis. Lancet 1995; 345: 136.
18. Seal D, Hay J, Kirkness C et al. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 1996; 10: 413-21.
19. Kosrirukvongs P, Wanachiwanawin D, Visvesvara GS. Treatment of keratitis with chlorhexidine. Ophthalmology 1999; 106: 798-802.
20. Ficker L, Seal D, Warhurst D, Wright P. Acanthamoeba keratitis-resistance to medical therapy. Eye 1990; 4: 835-8.
21. Oksuz H, Duran N, Tamer C, Cetin M, Silici S. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits. Ophthalmic Res 2005; 37: 328-34.
22. Murad JM, Calvi SA, Soares AM, Bankova V, Sforcin JM. Effects of propolis from Brazil and Bulgaria on fungicidal activity of macrophages against Paracoccidioides brasiliensis. J Ethnopharmacol 2002; 79: 331-4.
23. de Castro SL, Higashi KO. Effect of different formulations of propolis on mice infected with Trypanosoma cruzi. J Ethnopharmacol 1995; 46: 55-8.
24. Freitas SF, Shinohara L, Sforcin JM, Guimaraes S. In vitro effects of propolis on Giardia duodenalis trophozoites. Phytomedicine 2006; 13: 170-5.